chr3-165829704-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000055.4(BCHE):c.1330G>A(p.Ala444Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000055.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.1330G>A | p.Ala444Thr | missense_variant | 2/4 | ENST00000264381.8 | NP_000046.1 | |
BCHE | NR_137636.2 | n.1448G>A | non_coding_transcript_exon_variant | 2/5 | ||||
BCHE | NR_137635.2 | n.110+7610G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCHE | ENST00000264381.8 | c.1330G>A | p.Ala444Thr | missense_variant | 2/4 | 1 | NM_000055.4 | ENSP00000264381 | P1 | |
LINC01322 | ENST00000651449.1 | n.1008-16188C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152020Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250884Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135628
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461680Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727136
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74378
ClinVar
Submissions by phenotype
Pseudocholinesterase deficiency Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Dec 04, 2015 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2023 | The c.1330G>A (p.A444T) alteration is located in exon 2 (coding exon 1) of the BCHE gene. This alteration results from a G to A substitution at nucleotide position 1330, causing the alanine (A) at amino acid position 444 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at